S
Sweet Bio
Authentic Greek yogurt and healthy food products
About Sweet Bio
Sweet Bio is a food-biotech company that manufactures and distributes premium Greek yogurt under the brand name 'Greek Day'. Founded in 2016 by CEO Oh Jong-min, the company began with a small 3-square-meter store near Ewha Womans University after Oh, a former corporate employee with a degree in business administration from Seoul National University, decided to create a healthier food option for himself. Inspired by the growth of yogurt brands in the U.S. like Chobani, Oh researched and developed a unique recipe for Greek yogurt that suited the Korean palate, focusing on a thick texture and rich, savory taste by removing a significant amount of whey and using only raw milk and lactic acid bacteria without additives.
The company operates on a multi-channel sales model, combining both online and offline strategies. Revenue is generated through sales from its official online mall, major e-commerce platforms like Market Kurly and Coupang Fresh where it holds a top market share, and through its physical stores. Sweet Bio has expanded to 11 offline locations, primarily in Seoul, including a 24-hour Mediterranean-themed grocery store concept called 'Greek Day Go' in Apgujeong. The business serves health-conscious consumers, offering various yogurt products like the 'Signature' and 'Light' versions, drinkable yogurt, and other items such as granola, compotes, and baked goods.
Sweet Bio has achieved significant growth, with its revenue increasing from 2.8 billion KRW in 2020 to 26.1 billion KRW in 2023. The company has successfully raised capital through several funding rounds, including a Series A of 3 billion KRW in 2020, a Series B of 10.5 billion KRW in 2022, and a Series B bridge investment of 200 million JPY (approx. 1.74 billion KRW) in 2024 to fuel its expansion. With a new production facility in Sejong City, Sweet Bio is scaling up its manufacturing capabilities and is preparing for global expansion, starting with a flagship store in Tokyo, Japan.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jul 2024 | $1.5M | $44M | Lotte Ventures Japan | ↗ |
| SERIES B✓Equity / VC | Dec 2022 | $8.8M | $35M | Hanwha · Innopolis Partners · Korea Development Bank · BA Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sweet Bio is 27K monthly website visits, down 54.2% over the last three months. Sweet Bio's team declined 37.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- BPBA Partners
- IPInnopolis Partners
Hanwha
Korea Development Bank- DIDonghun Investment
Lotte Ventures Japan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sweet Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sweet Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






